NanoSphere Health Sciences Inc. (CSE: NSHS)
Canada
· Delayed Price · Currency is CAD 0.0600
-0.0250 (-29.41%)
Dec 19, 2024, 2:35 PM EST
CSE: NSHS Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 30, 2021 | Dec '20 Dec 30, 2020 | Dec '19 Dec 30, 2019 | 2018 - 2014 |
| Revenue | - | - | - | - | - | 0.22 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | 475.58% | Upgrade
|
| Gross Profit | - | - | - | - | - | 0.22 | Upgrade
|
| Selling, General & Admin | 0.16 | 0.19 | 0.23 | 0.27 | 0.44 | 1.59 | Upgrade
|
| Research & Development | 0.02 | 0.02 | 0.03 | 0.06 | - | 0 | Upgrade
|
| Operating Expenses | 0.18 | 0.22 | 0.26 | 0.36 | 0.54 | 2.05 | Upgrade
|
| Operating Income | -0.18 | -0.22 | -0.26 | -0.36 | -0.54 | -1.83 | Upgrade
|
| Interest Expense | -0 | - | - | - | -0.01 | -0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | 0.01 | 0 | 0 | 0.01 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | -0.02 | -0.02 | -0.03 | -0.01 | -0.34 | Upgrade
|
| EBT Excluding Unusual Items | -0.2 | -0.23 | -0.28 | -0.38 | -0.56 | -2.19 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.01 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.03 | -0.23 | Upgrade
|
| Other Unusual Items | - | - | - | 0.03 | -0 | -1.06 | Upgrade
|
| Pretax Income | -0.2 | -0.23 | -0.28 | -0.36 | -0.59 | -3.47 | Upgrade
|
| Net Income | -0.2 | -0.23 | -0.28 | -0.36 | -0.59 | -3.47 | Upgrade
|
| Net Income to Common | -0.2 | -0.23 | -0.28 | -0.36 | -0.59 | -3.47 | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 7 | 5 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 7 | 5 | 5 | Upgrade
|
| Shares Change (YoY) | - | - | 50.77% | 25.79% | 0.90% | 10.97% | Upgrade
|
| EPS (Basic) | -0.02 | -0.02 | -0.03 | -0.05 | -0.11 | -0.65 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.02 | -0.03 | -0.05 | -0.11 | -0.65 | Upgrade
|
| Free Cash Flow | -0.03 | -0.05 | -0.07 | -0.06 | -0.05 | -1.13 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.21 | Upgrade
|
| Gross Margin | - | - | - | - | - | 100.00% | Upgrade
|
| Operating Margin | - | - | - | - | - | -840.83% | Upgrade
|
| Profit Margin | - | - | - | - | - | -1590.92% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -519.42% | Upgrade
|
| EBITDA | - | - | - | -0.34 | -0.53 | -1.78 | Upgrade
|
| D&A For EBITDA | - | - | - | 0.01 | 0.01 | 0.05 | Upgrade
|
| EBIT | -0.18 | -0.22 | -0.26 | -0.36 | -0.54 | -1.83 | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 0.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.